Biodesix and MRM Proteomics partner to develop precision lung cancer diagnostics

Biodesix and MRM Proteomics partner to develop precision lung cancer diagnostics

BOULDER-- Biodesix and Canada-based MRM Proteomics Inc. announced they will partner to create novel assays to answer critical clinical questions within the lung cancer continuum of care. ... Read More

Tuesday January 29, 2019 0 comments Tags: Boulder, Biodesix, MRM Proteomics, Scott Hutton, lung cancer